Daily News

A new pathway against glioblastoma

A new pathway against glioblastoma

A new pathway against glioblastoma

Researchers have linked a cellular transport pathway to glioblastoma multiforme
Maximum attention on minimal residual disease

Maximum attention on minimal residual disease

Maximum attention on minimal residual disease

GRAIL announces collaborations with three industry giants to evaluate its platform in cancer MRD testing
bluebird’s oncology business takes wing

bluebird’s oncology business takes wing

bluebird’s oncology business takes wing

Company shares plans to spin out oncology business and retain severe genetic disease business
PacBio, Invitae set sights on whole-genome sequencing

PacBio, Invitae set sights on whole-genome sequencing

PacBio, Invitae set sights on whole-genome sequencing

The companies are aiming to develop a new production-scale platform to expand clinical adoption of whole-genome sequencing
Mast cells: the mechanism behind IBS

Mast cells: the mechanism behind IBS

Mast cells: the mechanism behind IBS

Researchers have discovered that mast cell reactions are behind irritable bowel syndrome
OXGENE aims at antibodies with SLIM

OXGENE aims at antibodies with SLIM

OXGENE aims at antibodies with SLIM

SLIM protein discovery method will identify antibodies against membrane proteins in their native configuration
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all the latest DDN news!

Latest Issue's Magazine Cover

Latest Issue  

• Volume 17 • Issue 1 • January 2021

December 2020/January 2021

December 2020/January 2021 issue